ஆல்பர்ட்டா பத்திரங்கள் தரகு ஆட்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆல்பர்ட்டா பத்திரங்கள் தரகு ஆட்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆல்பர்ட்டா பத்திரங்கள் தரகு ஆட்சி Today - Breaking & Trending Today

Hemostemix Inc.: Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

Hemostemix Inc.: Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Thomas Smeenk , Venture Exchange The , Alberta Securities Commission Rule , United States District Court , Common Shares Of The Company Debenture , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Accudata Solutions Inc , Hemostemix Inc , Polices Of The Exchange , Alberta Newsfile Corp , Venture Exchange , Company Common Share , Health Sciences , Debenture Units , Unit Offering , Each Unit , Common Share , Common Shares , Each Finder , Existing Shareholder Exemption , Existing Shareholder , Investment Dealer Exemption , Debenture Offering ,

Hemostemix Inc.: Hemostemix Announces Private Placement Update

Hemostemix Inc.: Hemostemix Announces Private Placement Update
Hemostemix or the
Company ) announces that it was granted price protection of its previously announced non-brokered private placement of units (
Units ) announced on December 18, 2020, for gross proceeds of up to $2,750,000 (the
Offering ). The Offering will consist of the issuance of an aggregate of up to 9,166,666 post rollback Units at a price of $0.30 per Unit. Each Unit consists of one post rollback common share in the capital of the Company (
Common Share ) and one post rollback common share purchase warrant (
Warrant ), with each full Warrant entitling the holder to acquire one Common Share at a price of $1.00 per Common Share for a period of 12 months from the closing of the Offering, subject to the accelerated expiry provision described below. ....

United States , Thomas Smeenk , Kostenloser Wertpapierhandel , Alberta Securities Commission Rule , Exchange On , Regulation Service Provider , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Venture Exchange , Alberta Newsfile Corp , Company Common Share , Each Unit , Common Share , Multilateral Instrument , Minority Security Holders , Special Transactions , Existing Security Holders , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , ஒன்றுபட்டது மாநிலங்களில் ,

Hemostemix Inc.: Hemostemix Announces Closing of Existing Private Placement and Announces a New Private Placement

Hemostemix Inc.: Hemostemix Announces Closing of Existing Private Placement and Announces a New Private Placement
Hemostemix or the
Units ) for gross proceeds of $1,272,117.04 (the
Offering ). The Offering consisted of the issuance of an aggregate of 127,211,704 Units at a price of $0.01 per Unit. Each Unit consists of one common share in the capital of the Company (
Common Share ) and one common share purchase warrant (
Warrant ), with each full Warrant entitling the holder to acquire one Common Share at a price of $0.05 per Common Share for a period of 12 months from the closing of the Offering, subject to the accelerated expiry provision described below. ....

United States , Thomas Smeenk , Kostenloser Wertpapierhandel , Alberta Securities Commission Rule , Regulation Service Provider , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Venture Exchange Inc , Venture Exchange , Alberta Newsfile Corp , Company Common Share , Each Unit , Common Share , Multilateral Instrument , Minority Security Holders , Special Transactions , Each Warrant , Existing Security Holders , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell ,